Design Therapeutics Stock Price History

DSGN Stock  USD 5.57  0.09  1.64%   
If you're considering investing in Design Stock, it is important to understand the factors that can impact its price. As of today, the current price of Design Therapeutics stands at 5.57, as last reported on the 21st of November, with the highest price reaching 5.73 and the lowest price hitting 5.43 during the day. Design Therapeutics appears to be moderately volatile, given 3 months investment horizon. Design Therapeutics secures Sharpe Ratio (or Efficiency) of 0.064, which denotes the company had a 0.064% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Design Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Design Therapeutics' Coefficient Of Variation of 1510.0, downside deviation of 5.91, and Mean Deviation of 4.28 to check if our risk estimates are consistent with your expectations.
  
At this time, Design Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 21st of November 2024, Sale Purchase Of Stock is likely to grow to about 307.3 K, while Total Stockholder Equity is likely to drop about 213.9 M. . At this time, Design Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 21st of November 2024, Price To Book Ratio is likely to grow to 0.56, while Price To Sales Ratio is likely to drop about 2.5 M. Design Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.064

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsDSGN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.78
  actual daily
51
51% of assets are less volatile

Expected Return

 0.37
  actual daily
7
93% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
5
95% of assets perform better
Based on monthly moving average Design Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Design Therapeutics by adding it to a well-diversified portfolio.
Price Book
1.2291
Enterprise Value Ebitda
(0.84)
Price Sales
22.6 K
Shares Float
25.2 M
Wall Street Target Price
7

Design Therapeutics Stock Price History Chart

There are several ways to analyze Design Stock price data. The simplest method is using a basic Design candlestick price chart, which shows Design Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 13, 20247.5
Lowest PriceOctober 7, 20244.56

Design Therapeutics November 21, 2024 Stock Price Synopsis

Various analyses of Design Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Design Stock. It can be used to describe the percentage change in the price of Design Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Design Stock.
Design Therapeutics Price Daily Balance Of Power 0.30 
Design Therapeutics Price Rate Of Daily Change 1.02 
Design Therapeutics Accumulation Distribution 5,244 
Design Therapeutics Price Action Indicator 0.04 

Design Therapeutics November 21, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Design Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Design Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Design Stock and then apply it to test your longer-term investment strategies against Design.

Design Stock Price History Data

The price series of Design Therapeutics for the period between Fri, Aug 23, 2024 and Thu, Nov 21, 2024 has a statistical range of 2.94 with a coefficient of variation of 10.07. Under current investment horizon, the daily prices are spread out with arithmetic mean of 5.38. The median price for the last 90 days is 5.38.
OpenHighLowCloseVolume
11/21/2024 5.57  5.73  5.43  5.57  100,167 
11/20/2024 5.47  5.51  5.34  5.48  72,195 
11/19/2024 5.65  5.70  5.32  5.48  86,161 
11/18/2024 5.81  5.81  5.40  5.76  146,684 
11/15/2024 5.91  5.98  5.61  5.80  240,269 
11/14/2024 7.51  7.54  5.71  6.02  312,401 
11/13/2024 6.95  7.77  6.95  7.50  397,611 
11/12/2024 6.52  6.95  6.43  6.91  204,614 
11/11/2024 5.88  6.83  5.76  6.61  249,308 
11/08/2024 5.77  5.93  5.32  5.83  161,253 
11/07/2024 5.92  6.20  5.76  5.79  109,129 
11/06/2024 5.75  6.12  5.57  5.94  202,379 
11/05/2024 5.34  5.57  5.25  5.56  95,660 
11/04/2024 5.15  5.34  5.05  5.32  85,999 
11/01/2024 5.28  5.30  5.05  5.20  69,394 
10/31/2024 5.57  5.63  5.22  5.24  71,393 
10/30/2024 5.37  5.59  5.29  5.57  89,194 
10/29/2024 5.50  5.50  5.22  5.41  58,923 
10/28/2024 5.54  5.74  5.36  5.53  64,920 
10/25/2024 5.40  5.49  5.31  5.44  66,282 
10/24/2024 5.68  5.78  5.33  5.35  55,931 
10/23/2024 5.60  5.69  5.47  5.66  77,338 
10/22/2024 5.56  5.78  5.43  5.67  80,199 
10/21/2024 5.56  5.72  5.33  5.60  110,148 
10/18/2024 6.01  6.01  5.31  5.60  144,847 
10/17/2024 5.67  6.02  5.61  6.02  627,021 
10/16/2024 5.45  5.73  5.39  5.65  123,488 
10/15/2024 5.16  5.43  5.14  5.39  114,865 
10/14/2024 5.00  5.19  4.95  5.15  142,936 
10/11/2024 4.63  5.01  4.63  5.00  203,948 
10/10/2024 4.63  4.68  4.50  4.67  80,755 
10/09/2024 4.92  4.92  4.62  4.68  156,824 
10/08/2024 4.53  4.93  4.49  4.92  187,206 
10/07/2024 5.00  5.01  4.49  4.56  137,774 
10/04/2024 4.79  5.02  4.70  5.00  200,998 
10/03/2024 4.96  4.96  4.51  4.72  240,682 
10/02/2024 5.15  5.16  4.66  4.97  385,304 
10/01/2024 5.36  5.36  5.00  5.15  273,586 
09/30/2024 5.32  5.44  5.25  5.38  112,423 
09/27/2024 5.49  5.62  5.30  5.33  135,951 
09/26/2024 5.49  5.54  5.34  5.42  85,399 
09/25/2024 5.41  5.50  5.31  5.38  102,157 
09/24/2024 5.38  5.46  5.21  5.41  164,564 
09/23/2024 5.92  5.92  5.35  5.35  195,454 
09/20/2024 5.82  6.13  5.77  5.88  639,321 
09/19/2024 5.79  5.95  5.71  5.86  156,793 
09/18/2024 5.75  5.87  5.56  5.64  196,341 
09/17/2024 5.62  5.96  5.55  5.77  285,080 
09/16/2024 5.57  5.86  5.44  5.55  173,713 
09/13/2024 5.85  5.97  5.20  5.54  291,282 
09/12/2024 5.36  6.01  5.35  5.84  376,987 
09/11/2024 5.65  5.79  5.05  5.22  465,133 
09/10/2024 5.10  6.91  4.98  5.64  4,506,059 
09/09/2024 4.58  4.97  4.58  4.88  162,029 
09/06/2024 4.72  4.79  4.50  4.67  97,175 
09/05/2024 4.85  4.85  4.60  4.71  87,949 
09/04/2024 4.67  4.87  4.52  4.81  86,184 
09/03/2024 4.77  4.86  4.61  4.73  83,131 
08/30/2024 4.74  4.95  4.54  4.75  98,051 
08/29/2024 4.77  4.93  4.66  4.71  94,558 
08/28/2024 4.86  5.03  4.63  4.71  74,932 

About Design Therapeutics Stock history

Design Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Design is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Design Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Design Therapeutics stock prices may prove useful in developing a viable investing in Design Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding56 M46.6 M
Net Loss-57 M-54.1 M

Design Therapeutics Quarterly Net Working Capital

258.45 Million

Design Therapeutics Stock Technical Analysis

Design Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Design Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Design Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

Design Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Design Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Design Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Design to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Design Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Design Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Design Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Design Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Design Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.85)
Revenue Per Share
0.001
Return On Assets
(0.14)
Return On Equity
(0.18)
The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.